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Abstract
Aim The modified Delphi approach is an established
method for reaching a consensus opinion among a
group of experts in a particular field. We have used this
technique to survey the entire membership of the Asso-
ciation of Coloproctology of Great Britain and Ireland
(ACPGBI) to reach a consensus on prioritizing clinical
research questions in colorectal disease.
Method Three rounds of surveys were conducted using
a web-based tool. In the first, the ACPGBI membership
was invited to submit research questions. In Rounds 2
and 3 they were asked to score questions on priority. A
steering group analysed the results of each round to
identify those questions ranked as being of highest pri-
ority.
Results Five hundred and two questions were submit-
ted in Round 1. Following two rounds of voting and
analysis, a list of 25 priority questions was produced,
including 15 cancer-related and 10 noncancer-related
questions.
Conclusion It is anticipated that these results will: (i)
set the research agenda over the next few years for the
study of colorectal disease in the United Kingdom, (ii)
promote development and (iii) define funding of new
research and prioritize areas of unmet clinical need
where the potential clinical impact is greatest.
Keywords Delphi, ACPGBI, colorectal research
priorities
What does this paper add to the literature?
This paper sets forth the research agenda in colorectal
surgery as determined by a modified Delphi process
involving a group of experts to identify and prioritize
the research questions of greatest clinical importance in
current colorectal practice. Its strength lies in the
involvement of the entire membership of the Associa-
tion of Coloproctology of Great Britain and Ireland.
Introduction
Research in surgery may be more challenging than in
other disciplines, leading to a relative lack of high-
quality randomized controlled trials [1,2]. Some
aspects of surgery, such as the learning curve for a
new procedure or measurement of technical quality,
present specific problems with trial design. There is
risk of bias and true clinical equipoise is difficult to
achieve. While an individual surgeon may lack certainty
about a specific intervention or choice of interventions,
the surgical community is likely to include a majority
of individuals who may have only have a little uncer-
tainty but who are unable together to agree a com-
mon position. This in turn has an impact on trial
recruitment.
It is difficult for investigators and funding bodies to
judge the potential impact of an innovation, technique
or management strategy. A list of colorectal research
questions with the greatest potential for improving
patient care would aid investigators and funding bodies
to address these problems and persuade clinicians to
cooperate to resolve uncertainty in these areas.
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The modified Delphi approach is an established
method for reaching a consensus opinion among a
group of experts in a particular field [3,4]. It is an itera-
tive process, commonly used in health and social sci-
ences, to determine the extent to which a group of
experts agree on a particular issue. It was used by the
American Society of Colon and Rectal Surgeons to
establish a research agenda, which was published in
2009 [5]. Elsewhere in colorectal surgery, the modified
Delphi method has been applied to anastomotic leakage
[6], classification of complications [7], development of
core outcome sets after colorectal surgery [8], quality
indicators for colorectal cancer care [9,10], criteria for
resectability in recurrent rectal cancer [11], develop-
ment of laparoscopic training tools [12] and assessment
of fitness for discharge from hospital after colorectal
surgery [13].
We have used this technique to survey the entire
membership of the Association of Coloproctology of
Great Britain and Ireland (ACPGBI) with the aim of
reaching a consensus on those research questions that
our members, as the expert panel, considered to reflect
the clinical issues of greatest importance in treating
colorectal pathology. These will then be the focus of
future grant applications, funding streams and recruit-
ment drives. They will act as a guide for future investi-
gators, funders and editors alike, allowing justification
of project proposals and a guide to the potential clinical
impact.
Method
The modified Delphi method involves collecting the
individual anonymized opinions of a group of experts
and refining these through controlled feedback and sta-
tistical analysis in a series of ‘rounds’. We conducted
three rounds using a web-based tool (https://www.sur-
veymonkey.net/). In each round, members were invited
to participate by e-mail and the survey was open for a
period of at least 5 weeks. Three reminder e-mails were
sent following the initial invitation for each round. A
nine-person steering group was formed to guide the
process. It consisted of colorectal surgeons, a trainee
surgeon, a clinical trials unit representative, a patient
representative, an oncologist and a representative from
the National Institute for Health Research (NIHR).
In Round 1, the entire ACPGBI membership was
asked to submit research questions that they consid-
ered most important to practising ACPGBI members.
There was no upper limit to the number of questions
that each member could submit and no limit on
choice of topic. The steering group then met and col-
lated the questions, categorizing them by consensus
into topics and amalgamating the various questions
relating to the same fundamental issue into a single
question. Care was taken to ensure that the underlying
meaning of a question was not altered and no ques-
tion was removed.
This process resulted in a list of questions for priori-
tization in Round 2. The ACPGBI membership was
invited, as the expert panel, to score each and every
research question on a numeric scale. Respondents
assigned a score of between one (low priority) and five
(high priority) to each question and were not permitted
to leave a question unscored to avoid ‘ambush’ voting
for just a few specific topics by interested parties.
The mean score, calculated from the percentage of
high-priority (five) and low-priority (one) scores was
calculated for each question and the questions then
ranked accordingly. The steering group discussed the
results and agreed by consensus to use the 45 highest
scoring questions in Round 3. This cut-off point was
chosen as there was a clear reduction in score for ques-
tions below 45 and the number was regarded to be
manageable for use in Round 3.
ACPGBI members were asked to re-score the 45
questions in Round 3 with the same scoring techniques
as used in Round 2. Analysis of the results was again
undertaken using a composite scoring technique and
questions ranked according to mean score and propor-
tion of high/low scores. The steering group discussed
the results and agreed on a final list of 25 questions that
were considered to represent the consensus opinion on
priority research questions.
Results
In Round 1, 1117 members in all categories (including
allied professions and retired members) were invited to
participate in the process (Fig. 1). One hundred and
twenty-eight (11.5%) responded, providing 502 ques-
tions with a mean of 3.9 questions per member. This
compared favourably with the experience in a similar
project conducted by the American Society of Colon
and Rectal Surgeons (9.4% and 3.7 questions/member)
[5]. The categories of the submitted questions are
shown in Table 1. The 215 cancer questions included
32 on chemoradiotherapy, 28 on basic science, 22 on
advanced disease, 21 relating to cancer management, 21
on surgical technique, 21 on early rectal cancer, 20 on
cancer screening, 17 on quality measures and outcome,
16 on complete pathological response, 9 on follow-up,
5 on diagnostics and 3 on anal cancer. The steering
group categorized each question, and amalgamation of
entries asking the same fundamental question resulted
in a list of 114 questions for Round 2.
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For Rounds 2 and 3 an updated membership list
(following a database upgrade by ACPGBI) of 918 cur-
rent, practising members was used. One hundred and
thirty-eight members completed the scoring process in
Round 2, giving a 15% response rate. The top 45 ques-
tions selected for scoring in Round 3 included 28 on
cancer topics, 7 on benign disease, 7 related to surgical
techniques and perioperative care and 3 related to out-
come, research methodology and training.
One hundred and sixty-three members (17.8%) suc-
cessfully completed the Round 3 survey. Overall 239/
918 (26%) ACPGBI members took part in Rounds 2
and/or 3. The top 25 research questions included 15
relating to colorectal cancer (Table 2) and 10 relating
to topics other than cancer (Table 3), including benign
disease, surgical technique and clinical governance.
Discussion
The modified Delphi method has produced a list of 25
research questions that can be considered to reflect the
clinical matters of greatest importance in treating colo-
rectal disease chosen by consensus of an expert panel of
ACPGBI members. This is the first attempt to engage
the entire ACPGBI membership to decide on research
priorities that may have an impact on their practice.
The modified Delphi process has been criticized as it
often involves only a small ‘expert panel’ which intro-
duces its own bias into studies. By widening the expert
panel to include all members of the ACPGBI, this
source of bias was largely avoided and this feature is
one of the major strengths of the exercise. Another
important advantage is the involvement of nonacademic
ACPGBI members as well as academic surgeons. Typi-
cally, research proposals and funding body grant reviews
tend to be undertaken by academic surgeons with spe-
cific research interests. It is hoped that this project has
enabled a diverse range of research questions to be sub-
mitted for consideration and a realistic consensus on
priority according to the potential clinical impact.
It is not surprising that research questions relating to
colorectal cancer were predominant in all three rounds,
but over a third of the final list constituted questions
on noncancer matters. The top three cancer questions
all reflected debate about the best management of rectal
cancer and polyp cancers in an era when treatment is
evolving towards organ preservation, with the important
question whether the cancer-specific results will be
Table 1 Topics of the questions included in each round.
Topic
Submitted by expert
panel in Round 1
Collated questions
for Round 2 voting
Highest scorers for
Round 3 voting
Final list of prioritized
research questions
Total 502 114 45 25
Cancer 215 47 30 15
Emergency surgery including
diverticular disease
46 12 4 1
Pelvic floor 43 8 1 1
Proctology 43 8 1 –
Surgical technique and perioperative care 33 6 1 1
Inflammatory bowel disease 33 7 2 2
Education/audit/governance 32 9 2 1
Complications of surgery 20 10 4 4
Innovation 18 4 – –
Endoscopy 12 3 – –
Miscellaneous 7 0 – –
Round 1 
Round 2 
Round 3 
1117 experts invited
128 respondents
502 questions 
114 questions
163 respondents
138 respondents
45 priority 
918 experts invited
Steering group 
Steering group 
Steering group 
918 experts invited
25 priority 
Figure 1 An overview of the modified Delphi process to prior-
itize research questions for the ACPGBI.
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maintained in the process. The second highest scoring
cancer question was almost identical to the experience
of the American Society of Colon and Rectal Surgeons
2009 exercise where ‘How can we identify which rectal
cancer patients have had complete pathologic response
to neoadjuvant therapy and what is the best treatment
for them?’ was the top scorer [5].
Cancer receives a generous proportion of available
research funding, but the authors welcome the relative
importance given to benign disease by the ACPGBI
membership. Four of the top-scoring noncancer ques-
tions related to prevention and treatment of colorectal
complications, including anastomotic leakage, parasto-
mal hernia, ileus and intra-abdominal sepsis and a fifth
Table 2 Highest priority list of cancer-related questions.
1 What is the optimal treatment for early rectal cancer? What are the relative roles of endoscopic mucosal resection (EMR),
transanal endoscopic microsurgery (TEMS), radiotherapy, chemotherapy and resectional surgery? In cases of early rectal cancer
amenable to local excision techniques, are there benefits from additional treatment modalities?
2 What is the best method for predicting complete pathological response to chemoradiotherapy in rectal cancer treated with
neoadjuvant chemoradiotherapy prior to surgery? Do these patients require immediate resectional surgery? If not, what is
the best strategy for surveillance?
3 What is the optimal treatment for endoscopically removed polyp cancers? When is surgical resection necessary? What is
the long-term outcome of polyp cancers treated with polypectomy alone?
4 What are the short- and long-term outcomes after extralevator abdominoperineal excision of rectum (ELAPE)? Is there an
oncological gain and is it justified?
5 What biomarkers (including genetic profiling) affect the response to chemoradiotherapy for rectal cancer?
6 Why do some patients develop colorectal cancer metastases? Can early markers of metastatic disease be developed?
7 What is the optimal timing of resection of liver and/or lung metastases from colorectal cancer – before, during or after
primary surgery?
8 What is the optimal method of wound closure after abdominoperineal excision of rectum (APER)? In which situations are
mesh or plastic reconstruction indicated, and is there a benefit from these techniques?
9 Is there a benefit to preoperative (chemo)radiotherapy in T3 rectal cancer with nonthreatened margins? If so, does it justify
any potential additional toxicity?
10 Is chemotherapy better given before or after surgery for locally advanced colon cancer? Or both before and after?
11 Is there a price to cancer survival after treatment for colon, rectal and anal cancer? What is the impact of treatment on quality
of life? What level of poor function is justified to avoid a permanent stoma?
12 What is the role of delayed resection of the primary tumour in chemoresponsive metastatic colorectal cancer?
13 What are the optimal methods and intervals for population screening for colorectal cancer? How can uptake of screening be
improved? Are there subgroups of the population who are at higher risk and should be screened earlier or at different
intervals?
14 Which colorectal adenomas indicate significantly increased risk of future colorectal cancer? What is the optimal screening
strategy for these patients?
15 What is the optimal surveillance strategy for patients who have undergone transanal local excision of rectal cancer?
Table 3 Highest priority list of noncancer-related questions.
1 How can early detection and outcome of anastomotic leakage be improved? Are there any new techniques or approaches
that will reduce anastomotic leak rates in colorectal surgery?
2 What is the best method of (1) preventing parastomal hernia formation and (2) repairing parastomal hernia?
3 What are the indications for, and what is the optimal timing of, surgery for Crohn’s disease in the era of biological therapy?
4 What are the short- and long-term outcomes of minimally invasive approaches (e.g. percutaneous radiological drainage,
laparoscopic washout and drainage) to managing complicated diverticulitis?
5 How can postoperative ileus be reduced?
6 What is the optimal multimodal strategy for managing fistulating perianal Crohn’s disease?
7 How does reporting and sharing of surgeon-specific outcomes affect clinical practice?
8 What are the short- and long-term outcomes of laparoscopic ventral mesh rectopexy (VMR) and is the mesh material used
important?
9 What are the predictive factors for poor outcome in patients with severe intra-abdominal sepsis? How can the outcome be
improved?
10 When should a colorectal anastomosis be defunctioned? Are there predictive factors which would aid decision-making about
the need for diversion?
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to weighing up the need for a defunctioning stoma.
Further questions related to key aspects of multimodal
treatment for inflammatory bowel disease and to increas-
ingly conservative approaches to the management of
diverticulitis. Early detection of anastomotic leakage is
clearly a consistent concern among colorectal surgeons,
as it was highlighted as an important area of research in
2013 [14] and the development of a signature diagnos-
tic test to allow earlier detection of anastomotic leakage
with emerging technologies based on detection of local
biomarkers is now the subject of a NIHR Colorectal
Therapies Healthcare Technology Co-operative project
(http://colorectal.htc.nihr.ac.uk/ongoing-projects/ear-
lier-detection-of-anastomotic-leak/).
In the UK, surgeons are now obliged by law to pub-
lish their results for anyone to see. The high prioritiza-
tion of a research question relating to such national
reporting reflects the topicality and importance with
which this development is regarded by the members of
ACBGBI. The inclusion of this question underpins the
concern that the reporting of isolated negative out-
comes out of context may result in patient harm if clini-
cal practice changes through political pressure to
publish individual surgeons’ results.
There are of course limitations to this type of
study. The ideal modified Delphi process would have
involved all ACPGBI members participating in all
rounds. In reality between 11.5% and 17.8% partici-
pated and many did not contribute to every round.
Despite this the number of respondents was still large,
with over 500 questions submitted and over 400 votes
registered. There was also a gradual increase in interest
from the membership as the project progressed, with a
quarter of ACPGBI members contributing to the final
two rounds. The wide variety of academic and subspe-
cialty interests of participating ACPGBI members
means that the results give a unique and representative
view of where the focus of future colorectal research
should lie.
The question remains as to how this information
should be disseminated and used. Most importantly
there is a need to involve patient support groups in
developing these research questions and establishing
whether the questions resonate with patients as well as
clinicians. Funding bodies will be informed of the
results and urged to consider prioritization of research
addressing these questions. Vignettes will be prepared
for the NIHR. ACPGBI members will be encouraged
to champion specific research questions with research
ideas worked up in brainstorming days. The success or
otherwise of this exercise to identify a research strategy
for ACPGBI will ultimately be judged by what research
is actually being carried out in 5 years’ time.
It is anticipated that these results will set the research
agenda for the study of colorectal disease in the UK,
promote development and funding of new research and
prioritize areas of unmet clinical need where potential
clinical impact is greatest.
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